Chronic obstructive pulmonary disease with (acute) exacerbation
ICD-10 J44.1 is a billable code used to indicate a diagnosis of chronic obstructive pulmonary disease with (acute) exacerbation.
Chronic obstructive pulmonary disease (COPD) with acute exacerbation is characterized by a progressive decline in lung function, primarily due to chronic bronchitis and emphysema. Patients typically present with increased dyspnea, wheezing, cough, and sputum production, often triggered by respiratory infections, environmental pollutants, or non-compliance with medication. The anatomy involved includes the bronchi, bronchioles, and alveoli, where inflammation and obstruction lead to airflow limitation. Disease progression is marked by recurrent exacerbations, which can significantly impair quality of life and increase the risk of hospitalization. Diagnostic considerations include pulmonary function tests (PFTs) to assess airflow obstruction, imaging studies like chest X-rays or CT scans to evaluate lung structure, and clinical assessments to differentiate between stable COPD and acute exacerbations. Accurate diagnosis is crucial for effective management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J44.1 covers chronic obstructive pulmonary disease with acute exacerbation, which may include conditions such as acute bronchitis superimposed on COPD, exacerbations due to infections, or environmental factors leading to acute worsening of symptoms.
J44.1 should be used when a patient with a known diagnosis of COPD experiences an acute exacerbation, characterized by a significant increase in respiratory symptoms requiring additional treatment or hospitalization.
Documentation should include clinical notes detailing the patient's history of COPD, specific symptoms during the exacerbation, results from lung function tests, and any treatments administered during the exacerbation.
